Arogga, a health-tech startup based in Bangladesh, has successfully completed its seed funding round, securing $5.5 million to improve access to affordable and genuine medication in the country. The funds raised will support the expansion of Arogga’s operations and its mission to enhance healthcare accessibility in Bangladesh.
This round of funding builds on the .5 million raised by Arogga in the previous year and includes million in new capital. The funding round was led by The Venture Collective (TVC), a US-based venture capital firm, with participation from various other investors, including The Blue Collective (US), Iterative (Singapore), Stella Maris Partners (Mexico), as well as returning investors Ratios Ventures (UK), Sketchnote Partners (Spain), and Epic Angels (Singapore). Local Bangladeshi investors IDLC Finance and Startup Bangladesh Limited also participated in the funding.
Arogga was founded in December 2020 and is on a mission to provide genuine medicines and improve healthcare accessibility in Bangladesh. With this new funding, the startup plans to expand its operations and become a comprehensive healthcare platform offering services such as lab testing and doctor consultations, moving beyond online pharmacy services.
Read more: Sumaiya Chowdhury Triumphs at the 18th Asia Fitness Conference with 5 Gold Medals
Rosina Mazumder, co-founder and CEO of Arogga, expressed the company’s vision: “The priority remains on increasing penetration in the capital Dhaka and also expanding hubs to two other major cities by Q2 2024.”
Arogga’s app offers a user-friendly interface with a wide range of genuine medicines and healthcare products. Users can easily search for products, compare different medicines, request specific items, and even order medicines with a prescription. The platform currently serves more than 600,000 users and has experienced an eightfold increase in revenue since 2021.
Arogga is also set to launch a home lab testing service in November, further improving convenience and accessibility to critical healthcare diagnostics.
